Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Healthpeak Properties Inc V.DOC


Primary Symbol: DOC

Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT). The Company acquires, develops, owns, leases, and manages healthcare real estate across the United States. Its strategy is to invest in and manage real estate focused on healthcare discovery and delivery. It has a diversified portfolio of high-quality healthcare properties across three core asset classes of lab, outpatient medical, and continuing care retirement community (CCRC) real estate. The Company’s segments include Lab, Outpatient medical and CCRC. The lab segment properties contain laboratory and office space, are leased primarily to biotechnology, medical device and pharmaceutical companies, scientific research institutions, government agencies, and other organizations involved in the life science industry. The Outpatient Medical segment includes outpatient medical buildings and hospitals. Outpatient medical buildings typically contain physicians’ offices and examination rooms.


NYSE:DOC - Post by User

Comment by equity4481on Apr 08, 2021 4:25pm
113 Views
Post# 32958626

RE:RE:RE:RE:RE:Moving at pace

RE:RE:RE:RE:RE:Moving at paceI would agree that Cloudmd needs to consolidate the business now.

After Visionpros and Oncidium close they will still have $30M cash O/H and a run rate of $125M+. If they close these deals as scheduled it will take 3-6 months to roll them in take advantage of the synergies. I think the more important issue is the focus on organic growth, which IMO could be the "golden ticket" on both these deals.

Based on some of the really odd valuations which are in the market such as CARE and WELL, especially considering Cloudmd will be EBITDA positive, I could easily see them @$4-5.00 by yearend.


<< Previous
Bullboard Posts
Next >>